In this issue:
NSCLC mutation rates in Australia
Patient-centred outcomes in lung cancer screening
PTSD symptoms after lung resection
Combined modality therapy for stage IIIA NSCLC
Modafinil for fatigue in lung cancer
Preoperative chemotherapy for NSCLC
Pemetrexed vs docetaxel in advanced NSCLC
Epithelial phenotype for predicting response
Bevacizumab + pemetrexed for NSCLC
Aggressive therapy for NSCLC with brain involvement
Please login below to download this issue (PDF)